nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—lung cancer	0.218	1	CbGaD
Meloxicam—PGD—Methotrexate—lung cancer	0.12	0.259	CbGbCtD
Meloxicam—ABCC4—Methotrexate—lung cancer	0.0332	0.0714	CbGbCtD
Meloxicam—PTGS2—Cisplatin—lung cancer	0.0301	0.0647	CbGbCtD
Meloxicam—PTGS2—Etoposide—lung cancer	0.0296	0.0635	CbGbCtD
Meloxicam—PTGS1—Etoposide—lung cancer	0.025	0.0537	CbGbCtD
Meloxicam—CYP2C9—Gefitinib—lung cancer	0.0235	0.0505	CbGbCtD
Meloxicam—CYP2C9—Teniposide—lung cancer	0.0228	0.049	CbGbCtD
Meloxicam—CYP2C8—Erlotinib—lung cancer	0.0199	0.0428	CbGbCtD
Meloxicam—CYP2C8—Paclitaxel—lung cancer	0.0182	0.0392	CbGbCtD
Meloxicam—CYP3A4—Topotecan—lung cancer	0.0149	0.0321	CbGbCtD
Meloxicam—CYP2C8—Etoposide—lung cancer	0.0144	0.031	CbGbCtD
Meloxicam—CYP3A4—Gefitinib—lung cancer	0.0137	0.0294	CbGbCtD
Meloxicam—CYP3A4—Teniposide—lung cancer	0.0132	0.0285	CbGbCtD
Meloxicam—CYP2C9—Paclitaxel—lung cancer	0.0127	0.0273	CbGbCtD
Meloxicam—CYP3A4—Vinorelbine—lung cancer	0.0105	0.0226	CbGbCtD
Meloxicam—CYP2C9—Cisplatin—lung cancer	0.0102	0.022	CbGbCtD
Meloxicam—CYP3A4—Crizotinib—lung cancer	0.00837	0.018	CbGbCtD
Meloxicam—CYP3A4—Erlotinib—lung cancer	0.00808	0.0174	CbGbCtD
Meloxicam—CYP3A4—Paclitaxel—lung cancer	0.00739	0.0159	CbGbCtD
Meloxicam—CYP3A4—Irinotecan—lung cancer	0.00729	0.0157	CbGbCtD
Meloxicam—CYP3A4—Vinblastine—lung cancer	0.00648	0.0139	CbGbCtD
Meloxicam—CYP3A4—Etoposide—lung cancer	0.00584	0.0126	CbGbCtD
Meloxicam—CYP3A4—Docetaxel—lung cancer	0.00534	0.0115	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—lung cancer	0.00398	0.00857	CbGbCtD
Meloxicam—PGD—mammary gland—lung cancer	0.00151	0.115	CbGeAlD
Meloxicam—PGD—respiratory system—lung cancer	0.00101	0.0767	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—lung cancer	0.00084	0.341	CrCbGaD
Meloxicam—PGD—bronchus—lung cancer	0.000828	0.0631	CbGeAlD
Meloxicam—CYP2C8—mammary gland—lung cancer	0.000779	0.0594	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—lung cancer	0.000748	0.304	CrCbGaD
Meloxicam—PGD—trachea—lung cancer	0.000743	0.0567	CbGeAlD
Meloxicam—PGD—cardiac atrium—lung cancer	0.000698	0.0533	CbGeAlD
Meloxicam—CYP2C9—mammary gland—lung cancer	0.000692	0.0528	CbGeAlD
Meloxicam—PGD—bone marrow—lung cancer	0.000589	0.045	CbGeAlD
Meloxicam—ABCC4—bronchus—lung cancer	0.000589	0.0449	CbGeAlD
Meloxicam—PGD—lung—lung cancer	0.000534	0.0407	CbGeAlD
Meloxicam—Piroxicam—PTGS2—lung cancer	0.000462	0.188	CrCbGaD
Meloxicam—PTGS1—respiratory system—lung cancer	0.000421	0.0321	CbGeAlD
Meloxicam—ABCC4—bone marrow—lung cancer	0.000419	0.032	CbGeAlD
Meloxicam—Piroxicam—ALB—lung cancer	0.000412	0.167	CrCbGaD
Meloxicam—PTGS2—respiratory system—lung cancer	0.000403	0.0307	CbGeAlD
Meloxicam—ABCC4—lung—lung cancer	0.00038	0.029	CbGeAlD
Meloxicam—PGD—lymph node—lung cancer	0.000365	0.0279	CbGeAlD
Meloxicam—PTGS1—epithelium—lung cancer	0.000352	0.0268	CbGeAlD
Meloxicam—PTGS2—epithelium—lung cancer	0.000336	0.0257	CbGeAlD
Meloxicam—PTGS2—bronchus—lung cancer	0.000331	0.0253	CbGeAlD
Meloxicam—PTGS1—trachea—lung cancer	0.000311	0.0237	CbGeAlD
Meloxicam—PTGS2—trachea—lung cancer	0.000297	0.0227	CbGeAlD
Meloxicam—PTGS1—cardiac atrium—lung cancer	0.000292	0.0223	CbGeAlD
Meloxicam—ABCC4—lymph node—lung cancer	0.00026	0.0198	CbGeAlD
Meloxicam—PTGS2—bone marrow—lung cancer	0.000236	0.018	CbGeAlD
Meloxicam—PTGS1—lung—lung cancer	0.000224	0.0171	CbGeAlD
Meloxicam—PTGS2—lung—lung cancer	0.000214	0.0163	CbGeAlD
Meloxicam—PTGS1—lymph node—lung cancer	0.000153	0.0117	CbGeAlD
Meloxicam—PTGS2—lymph node—lung cancer	0.000146	0.0112	CbGeAlD
Meloxicam—Constipation—Paclitaxel—lung cancer	6.55e-05	0.000313	CcSEcCtD
Meloxicam—Confusional state—Docetaxel—lung cancer	6.55e-05	0.000313	CcSEcCtD
Meloxicam—Pharyngitis—Methotrexate—lung cancer	6.54e-05	0.000313	CcSEcCtD
Meloxicam—Urinary tract disorder—Methotrexate—lung cancer	6.5e-05	0.000311	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—lung cancer	6.5e-05	0.000311	CcSEcCtD
Meloxicam—Anaphylactic shock—Docetaxel—lung cancer	6.49e-05	0.000311	CcSEcCtD
Meloxicam—Oedema—Docetaxel—lung cancer	6.49e-05	0.000311	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—lung cancer	6.48e-05	0.00031	CcSEcCtD
Meloxicam—Pruritus—Gemcitabine—lung cancer	6.47e-05	0.00031	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—lung cancer	6.46e-05	0.000309	CcSEcCtD
Meloxicam—Infection—Docetaxel—lung cancer	6.45e-05	0.000309	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—lung cancer	6.45e-05	0.000308	CcSEcCtD
Meloxicam—Feeling abnormal—Etoposide—lung cancer	6.44e-05	0.000308	CcSEcCtD
Meloxicam—Diarrhoea—Irinotecan—lung cancer	6.43e-05	0.000307	CcSEcCtD
Meloxicam—Gastrointestinal pain—Etoposide—lung cancer	6.39e-05	0.000306	CcSEcCtD
Meloxicam—Shock—Docetaxel—lung cancer	6.39e-05	0.000306	CcSEcCtD
Meloxicam—Nervous system disorder—Docetaxel—lung cancer	6.37e-05	0.000305	CcSEcCtD
Meloxicam—Thrombocytopenia—Docetaxel—lung cancer	6.36e-05	0.000304	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—lung cancer	6.35e-05	0.000304	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—lung cancer	6.35e-05	0.000304	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—lung cancer	6.35e-05	0.000304	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—lung cancer	6.35e-05	0.000304	CcSEcCtD
Meloxicam—Tachycardia—Docetaxel—lung cancer	6.34e-05	0.000303	CcSEcCtD
Meloxicam—Feeling abnormal—Paclitaxel—lung cancer	6.31e-05	0.000302	CcSEcCtD
Meloxicam—Skin disorder—Docetaxel—lung cancer	6.31e-05	0.000302	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—lung cancer	6.3e-05	0.000301	CcSEcCtD
Meloxicam—Hypersensitivity—Cisplatin—lung cancer	6.28e-05	0.000301	CcSEcCtD
Meloxicam—Gastrointestinal pain—Paclitaxel—lung cancer	6.26e-05	0.0003	CcSEcCtD
Meloxicam—Diarrhoea—Gemcitabine—lung cancer	6.26e-05	0.0003	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—lung cancer	6.24e-05	0.000299	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—lung cancer	6.23e-05	0.000298	CcSEcCtD
Meloxicam—Dizziness—Irinotecan—lung cancer	6.21e-05	0.000297	CcSEcCtD
Meloxicam—Urticaria—Etoposide—lung cancer	6.21e-05	0.000297	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—lung cancer	6.19e-05	0.000296	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—lung cancer	6.19e-05	0.000296	CcSEcCtD
Meloxicam—Body temperature increased—Etoposide—lung cancer	6.17e-05	0.000296	CcSEcCtD
Meloxicam—Abdominal pain—Etoposide—lung cancer	6.17e-05	0.000296	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—lung cancer	6.17e-05	0.000295	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—lung cancer	6.17e-05	0.000295	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—lung cancer	6.15e-05	0.000295	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—lung cancer	6.14e-05	0.000294	CcSEcCtD
Meloxicam—Asthenia—Cisplatin—lung cancer	6.12e-05	0.000293	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—lung cancer	6.11e-05	0.000292	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—lung cancer	6.09e-05	0.000291	CcSEcCtD
Meloxicam—Urticaria—Paclitaxel—lung cancer	6.08e-05	0.000291	CcSEcCtD
Meloxicam—Hypotension—Docetaxel—lung cancer	6.07e-05	0.00029	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—lung cancer	6.06e-05	0.00029	CcSEcCtD
Meloxicam—Abdominal pain—Paclitaxel—lung cancer	6.05e-05	0.00029	CcSEcCtD
Meloxicam—Body temperature increased—Paclitaxel—lung cancer	6.05e-05	0.00029	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—lung cancer	6.01e-05	0.000288	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—lung cancer	5.97e-05	0.000286	CcSEcCtD
Meloxicam—Vomiting—Irinotecan—lung cancer	5.97e-05	0.000286	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—lung cancer	5.96e-05	0.000285	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—lung cancer	5.95e-05	0.000285	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—lung cancer	5.94e-05	0.000284	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—lung cancer	5.93e-05	0.000284	CcSEcCtD
Meloxicam—Rash—Irinotecan—lung cancer	5.92e-05	0.000283	CcSEcCtD
Meloxicam—Dermatitis—Irinotecan—lung cancer	5.92e-05	0.000283	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Docetaxel—lung cancer	5.91e-05	0.000283	CcSEcCtD
Meloxicam—Headache—Irinotecan—lung cancer	5.88e-05	0.000282	CcSEcCtD
Meloxicam—Insomnia—Docetaxel—lung cancer	5.87e-05	0.000281	CcSEcCtD
Meloxicam—Diarrhoea—Cisplatin—lung cancer	5.83e-05	0.000279	CcSEcCtD
Meloxicam—Paraesthesia—Docetaxel—lung cancer	5.83e-05	0.000279	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—lung cancer	5.82e-05	0.000278	CcSEcCtD
Meloxicam—Vomiting—Gemcitabine—lung cancer	5.82e-05	0.000278	CcSEcCtD
Meloxicam—Dyspnoea—Docetaxel—lung cancer	5.79e-05	0.000277	CcSEcCtD
Meloxicam—Somnolence—Docetaxel—lung cancer	5.77e-05	0.000276	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—lung cancer	5.77e-05	0.000276	CcSEcCtD
Meloxicam—Rash—Gemcitabine—lung cancer	5.77e-05	0.000276	CcSEcCtD
Meloxicam—Dermatitis—Gemcitabine—lung cancer	5.76e-05	0.000276	CcSEcCtD
Meloxicam—Hypersensitivity—Etoposide—lung cancer	5.75e-05	0.000275	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—lung cancer	5.73e-05	0.000274	CcSEcCtD
Meloxicam—Erythema—Methotrexate—lung cancer	5.73e-05	0.000274	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—lung cancer	5.73e-05	0.000274	CcSEcCtD
Meloxicam—Headache—Gemcitabine—lung cancer	5.73e-05	0.000274	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—lung cancer	5.72e-05	0.000274	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—lung cancer	5.71e-05	0.000273	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—lung cancer	5.7e-05	0.000273	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—lung cancer	5.7e-05	0.000273	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—lung cancer	5.66e-05	0.000271	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—lung cancer	5.64e-05	0.00027	CcSEcCtD
Meloxicam—Hypersensitivity—Paclitaxel—lung cancer	5.64e-05	0.00027	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—lung cancer	5.63e-05	0.00027	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—lung cancer	5.62e-05	0.000269	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—lung cancer	5.61e-05	0.000269	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Docetaxel—lung cancer	5.6e-05	0.000268	CcSEcCtD
Meloxicam—Asthenia—Etoposide—lung cancer	5.6e-05	0.000268	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—lung cancer	5.6e-05	0.000268	CcSEcCtD
Meloxicam—Fatigue—Docetaxel—lung cancer	5.6e-05	0.000268	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—lung cancer	5.59e-05	0.000268	CcSEcCtD
Meloxicam—Nausea—Irinotecan—lung cancer	5.58e-05	0.000267	CcSEcCtD
Meloxicam—Pain—Docetaxel—lung cancer	5.55e-05	0.000266	CcSEcCtD
Meloxicam—Constipation—Docetaxel—lung cancer	5.55e-05	0.000266	CcSEcCtD
Meloxicam—Back pain—Methotrexate—lung cancer	5.55e-05	0.000265	CcSEcCtD
Meloxicam—Pruritus—Etoposide—lung cancer	5.53e-05	0.000264	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—lung cancer	5.5e-05	0.000263	CcSEcCtD
Meloxicam—Asthenia—Paclitaxel—lung cancer	5.49e-05	0.000263	CcSEcCtD
Meloxicam—Nausea—Gemcitabine—lung cancer	5.43e-05	0.00026	CcSEcCtD
Meloxicam—Vomiting—Cisplatin—lung cancer	5.42e-05	0.000259	CcSEcCtD
Meloxicam—Pruritus—Paclitaxel—lung cancer	5.42e-05	0.000259	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—lung cancer	5.4e-05	0.000259	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—lung cancer	5.39e-05	0.000258	CcSEcCtD
Meloxicam—Rash—Cisplatin—lung cancer	5.38e-05	0.000257	CcSEcCtD
Meloxicam—Dermatitis—Cisplatin—lung cancer	5.37e-05	0.000257	CcSEcCtD
Meloxicam—Feeling abnormal—Docetaxel—lung cancer	5.35e-05	0.000256	CcSEcCtD
Meloxicam—Diarrhoea—Etoposide—lung cancer	5.34e-05	0.000256	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—lung cancer	5.33e-05	0.000255	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—lung cancer	5.32e-05	0.000255	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—lung cancer	5.32e-05	0.000254	CcSEcCtD
Meloxicam—Gastrointestinal pain—Docetaxel—lung cancer	5.31e-05	0.000254	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—lung cancer	5.3e-05	0.000254	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—lung cancer	5.29e-05	0.000253	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—lung cancer	5.29e-05	0.000253	CcSEcCtD
Meloxicam—Diarrhoea—Paclitaxel—lung cancer	5.24e-05	0.000251	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—lung cancer	5.17e-05	0.000248	CcSEcCtD
Meloxicam—Malaise—Methotrexate—lung cancer	5.17e-05	0.000247	CcSEcCtD
Meloxicam—Dizziness—Etoposide—lung cancer	5.17e-05	0.000247	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—lung cancer	5.15e-05	0.000246	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—lung cancer	5.15e-05	0.000246	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—lung cancer	5.14e-05	0.000246	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—lung cancer	5.13e-05	0.000246	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—lung cancer	5.13e-05	0.000246	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—lung cancer	5.13e-05	0.000246	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—lung cancer	5.09e-05	0.000244	CcSEcCtD
Meloxicam—Dizziness—Paclitaxel—lung cancer	5.06e-05	0.000242	CcSEcCtD
Meloxicam—Nausea—Cisplatin—lung cancer	5.06e-05	0.000242	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—lung cancer	5.04e-05	0.000241	CcSEcCtD
Meloxicam—Cough—Methotrexate—lung cancer	5e-05	0.000239	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—lung cancer	5e-05	0.000239	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—lung cancer	4.97e-05	0.000238	CcSEcCtD
Meloxicam—Vomiting—Etoposide—lung cancer	4.97e-05	0.000238	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—lung cancer	4.96e-05	0.000238	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—lung cancer	4.96e-05	0.000238	CcSEcCtD
Meloxicam—Rash—Etoposide—lung cancer	4.93e-05	0.000236	CcSEcCtD
Meloxicam—Dermatitis—Etoposide—lung cancer	4.92e-05	0.000235	CcSEcCtD
Meloxicam—Headache—Etoposide—lung cancer	4.89e-05	0.000234	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—lung cancer	4.89e-05	0.000234	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—lung cancer	4.88e-05	0.000234	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—lung cancer	4.88e-05	0.000234	CcSEcCtD
Meloxicam—Tension—Doxorubicin—lung cancer	4.87e-05	0.000233	CcSEcCtD
Meloxicam—Vomiting—Paclitaxel—lung cancer	4.87e-05	0.000233	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—lung cancer	4.86e-05	0.000233	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.85e-05	0.000232	CcSEcCtD
Meloxicam—Rash—Paclitaxel—lung cancer	4.83e-05	0.000231	CcSEcCtD
Meloxicam—Dermatitis—Paclitaxel—lung cancer	4.82e-05	0.000231	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—lung cancer	4.82e-05	0.000231	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—lung cancer	4.82e-05	0.000231	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—lung cancer	4.8e-05	0.00023	CcSEcCtD
Meloxicam—Headache—Paclitaxel—lung cancer	4.8e-05	0.00023	CcSEcCtD
Meloxicam—Hypersensitivity—Docetaxel—lung cancer	4.78e-05	0.000229	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—lung cancer	4.77e-05	0.000228	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—lung cancer	4.72e-05	0.000226	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—lung cancer	4.68e-05	0.000224	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—lung cancer	4.68e-05	0.000224	CcSEcCtD
Meloxicam—Asthenia—Docetaxel—lung cancer	4.66e-05	0.000223	CcSEcCtD
Meloxicam—Infection—Methotrexate—lung cancer	4.65e-05	0.000222	CcSEcCtD
Meloxicam—Nausea—Etoposide—lung cancer	4.64e-05	0.000222	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—lung cancer	4.61e-05	0.00022	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—lung cancer	4.59e-05	0.00022	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—lung cancer	4.59e-05	0.00022	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—lung cancer	4.59e-05	0.00022	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—lung cancer	4.58e-05	0.000219	CcSEcCtD
Meloxicam—Nausea—Paclitaxel—lung cancer	4.55e-05	0.000218	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—lung cancer	4.54e-05	0.000217	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—lung cancer	4.52e-05	0.000216	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—lung cancer	4.48e-05	0.000214	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—lung cancer	4.46e-05	0.000213	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—lung cancer	4.45e-05	0.000213	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—lung cancer	4.44e-05	0.000213	CcSEcCtD
Meloxicam—Diarrhoea—Docetaxel—lung cancer	4.44e-05	0.000213	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—lung cancer	4.39e-05	0.00021	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—lung cancer	4.37e-05	0.000209	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—lung cancer	4.36e-05	0.000209	CcSEcCtD
Meloxicam—Cough—Doxorubicin—lung cancer	4.33e-05	0.000207	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—lung cancer	4.3e-05	0.000206	CcSEcCtD
Meloxicam—Dizziness—Docetaxel—lung cancer	4.29e-05	0.000205	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—lung cancer	4.29e-05	0.000205	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—lung cancer	4.26e-05	0.000204	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—lung cancer	4.23e-05	0.000203	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—lung cancer	4.23e-05	0.000202	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—lung cancer	4.23e-05	0.000202	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—lung cancer	4.21e-05	0.000202	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—lung cancer	4.2e-05	0.000201	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.2e-05	0.000201	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—lung cancer	4.18e-05	0.0002	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—lung cancer	4.17e-05	0.0002	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—lung cancer	4.16e-05	0.000199	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—lung cancer	4.13e-05	0.000198	CcSEcCtD
Meloxicam—Vomiting—Docetaxel—lung cancer	4.13e-05	0.000198	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—lung cancer	4.12e-05	0.000197	CcSEcCtD
Meloxicam—Rash—Docetaxel—lung cancer	4.09e-05	0.000196	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—lung cancer	4.09e-05	0.000196	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—lung cancer	4.08e-05	0.000195	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—lung cancer	4.07e-05	0.000195	CcSEcCtD
Meloxicam—Headache—Docetaxel—lung cancer	4.07e-05	0.000195	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—lung cancer	4.05e-05	0.000194	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—lung cancer	4.05e-05	0.000194	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—lung cancer	4.04e-05	0.000193	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—lung cancer	4.03e-05	0.000193	CcSEcCtD
Meloxicam—Infection—Doxorubicin—lung cancer	4.02e-05	0.000193	CcSEcCtD
Meloxicam—Pain—Methotrexate—lung cancer	4e-05	0.000191	CcSEcCtD
Meloxicam—Shock—Doxorubicin—lung cancer	3.99e-05	0.000191	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—lung cancer	3.97e-05	0.00019	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—lung cancer	3.97e-05	0.00019	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—lung cancer	3.95e-05	0.000189	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—lung cancer	3.94e-05	0.000188	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—lung cancer	3.92e-05	0.000187	CcSEcCtD
Meloxicam—Nausea—Docetaxel—lung cancer	3.86e-05	0.000185	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—lung cancer	3.86e-05	0.000185	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—lung cancer	3.83e-05	0.000183	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—lung cancer	3.79e-05	0.000181	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—lung cancer	3.72e-05	0.000178	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—lung cancer	3.7e-05	0.000177	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—lung cancer	3.7e-05	0.000177	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.69e-05	0.000177	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—lung cancer	3.66e-05	0.000175	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—lung cancer	3.64e-05	0.000174	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—lung cancer	3.61e-05	0.000173	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—lung cancer	3.6e-05	0.000172	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—lung cancer	3.57e-05	0.000171	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—lung cancer	3.52e-05	0.000169	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—lung cancer	3.5e-05	0.000167	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—lung cancer	3.49e-05	0.000167	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—lung cancer	3.46e-05	0.000166	CcSEcCtD
Meloxicam—Pain—Doxorubicin—lung cancer	3.46e-05	0.000166	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—lung cancer	3.45e-05	0.000165	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—lung cancer	3.36e-05	0.000161	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—lung cancer	3.34e-05	0.00016	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—lung cancer	3.31e-05	0.000159	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—lung cancer	3.31e-05	0.000158	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—lung cancer	3.22e-05	0.000154	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—lung cancer	3.2e-05	0.000153	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—lung cancer	3.2e-05	0.000153	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—lung cancer	3.2e-05	0.000153	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—lung cancer	3.09e-05	0.000148	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—lung cancer	2.98e-05	0.000143	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—lung cancer	2.97e-05	0.000142	CcSEcCtD
Meloxicam—Rash—Methotrexate—lung cancer	2.95e-05	0.000141	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—lung cancer	2.95e-05	0.000141	CcSEcCtD
Meloxicam—Headache—Methotrexate—lung cancer	2.93e-05	0.00014	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—lung cancer	2.91e-05	0.000139	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—lung cancer	2.87e-05	0.000137	CcSEcCtD
Meloxicam—Nausea—Methotrexate—lung cancer	2.78e-05	0.000133	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—lung cancer	2.77e-05	0.000133	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—lung cancer	2.68e-05	0.000128	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—lung cancer	2.58e-05	0.000123	CcSEcCtD
Meloxicam—Rash—Doxorubicin—lung cancer	2.55e-05	0.000122	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—lung cancer	2.55e-05	0.000122	CcSEcCtD
Meloxicam—Headache—Doxorubicin—lung cancer	2.54e-05	0.000121	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—lung cancer	2.41e-05	0.000115	CcSEcCtD
Meloxicam—PTGS2—Metabolism—GSTT1—lung cancer	1.34e-05	0.000144	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—lung cancer	1.33e-05	0.000143	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2A6—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GCLC—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—UGT1A1—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JUNB—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—lung cancer	1.3e-05	0.00014	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.3e-05	0.00014	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—lung cancer	1.29e-05	0.000139	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GNG11—lung cancer	1.27e-05	0.000137	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.26e-05	0.000136	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—B4GALT5—lung cancer	1.26e-05	0.000136	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—STK11—lung cancer	1.26e-05	0.000136	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—lung cancer	1.26e-05	0.000136	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HSD17B10—lung cancer	1.26e-05	0.000135	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO1—lung cancer	1.25e-05	0.000135	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.25e-05	0.000135	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA4—lung cancer	1.23e-05	0.000132	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDOA—lung cancer	1.21e-05	0.000131	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—lung cancer	1.2e-05	0.00013	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.2e-05	0.000129	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA2—lung cancer	1.2e-05	0.000129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.18e-05	0.000128	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NCOA3—lung cancer	1.17e-05	0.000127	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CKB—lung cancer	1.17e-05	0.000126	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTP1—lung cancer	1.17e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.15e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA1—lung cancer	1.15e-05	0.000124	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FOXO3—lung cancer	1.15e-05	0.000124	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADCY1—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCG2—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCC3—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAT—lung cancer	1.13e-05	0.000122	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.13e-05	0.000122	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2E1—lung cancer	1.12e-05	0.000121	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO2—lung cancer	1.12e-05	0.000121	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HPGDS—lung cancer	1.12e-05	0.000121	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.11e-05	0.00012	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NQO1—lung cancer	1.11e-05	0.00012	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKR1C1—lung cancer	1.1e-05	0.000119	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—lung cancer	1.1e-05	0.000119	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.1e-05	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM2—lung cancer	1.1e-05	0.000118	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CNDP2—lung cancer	1.1e-05	0.000118	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.09e-05	0.000117	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—lung cancer	1.09e-05	0.000117	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMS—lung cancer	1.08e-05	0.000117	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—lung cancer	1.08e-05	0.000117	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GCLC—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2A6—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—UGT1A1—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—lung cancer	1.07e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.07e-05	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTMR3—lung cancer	1.07e-05	0.000115	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—lung cancer	1.06e-05	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PGAM1—lung cancer	1.04e-05	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GNG11—lung cancer	1.03e-05	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.03e-05	0.000111	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HES1—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO1—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A1—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.01e-05	0.000109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ERCC2—lung cancer	1.01e-05	0.000109	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1e-05	0.000108	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—STK11—lung cancer	1e-05	0.000108	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2A7—lung cancer	9.93e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDOA—lung cancer	9.85e-06	0.000106	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SDC4—lung cancer	9.72e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NCOA3—lung cancer	9.56e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERCC2—lung cancer	9.55e-06	0.000103	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.39e-06	0.000101	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.39e-06	0.000101	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB3—lung cancer	9.34e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCG2—lung cancer	9.3e-06	0.0001	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADCY1—lung cancer	9.3e-06	0.0001	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTP1—lung cancer	9.26e-06	9.99e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2E1—lung cancer	9.14e-06	9.86e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HPGDS—lung cancer	9.12e-06	9.84e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO2—lung cancer	9.12e-06	9.84e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP2R1B—lung cancer	9.06e-06	9.78e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NQO1—lung cancer	9.03e-06	9.74e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAT—lung cancer	9.01e-06	9.72e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.96e-06	9.66e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TERT—lung cancer	8.95e-06	9.66e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.94e-06	9.65e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—RRM1—lung cancer	8.85e-06	9.55e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA3—lung cancer	8.85e-06	9.55e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—lung cancer	8.85e-06	9.54e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.84e-06	9.54e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—lung cancer	8.76e-06	9.46e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.76e-06	9.45e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GCLC—lung cancer	8.74e-06	9.43e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2A6—lung cancer	8.74e-06	9.43e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOA1—lung cancer	8.72e-06	9.4e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.71e-06	9.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGFR1—lung cancer	8.69e-06	9.38e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMS—lung cancer	8.61e-06	9.29e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—lung cancer	8.56e-06	9.24e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—lung cancer	8.51e-06	9.18e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.35e-06	9.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—B4GALT5—lung cancer	8.32e-06	8.98e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO1—lung cancer	8.29e-06	8.94e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOA1—lung cancer	8.26e-06	8.91e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.26e-06	8.91e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.15e-06	8.8e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—STK11—lung cancer	8.14e-06	8.78e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA4—lung cancer	8.09e-06	8.73e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A1—lung cancer	8.07e-06	8.7e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ERCC2—lung cancer	8e-06	8.63e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—lung cancer	7.96e-06	8.59e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA2—lung cancer	7.89e-06	8.51e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.64e-06	8.25e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA1—lung cancer	7.61e-06	8.21e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—lung cancer	7.58e-06	8.17e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KIT—lung cancer	7.54e-06	8.14e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—lung cancer	7.54e-06	8.14e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTP1—lung cancer	7.53e-06	8.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCC3—lung cancer	7.52e-06	8.12e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGF—lung cancer	7.46e-06	8.04e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2E1—lung cancer	7.43e-06	8.02e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CREBBP—lung cancer	7.38e-06	7.96e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NQO1—lung cancer	7.35e-06	7.93e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAT—lung cancer	7.33e-06	7.91e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.29e-06	7.86e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKR1C1—lung cancer	7.29e-06	7.86e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.2e-06	7.77e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.13e-06	7.69e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—lung cancer	7.13e-06	7.69e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BRAF—lung cancer	7.09e-06	7.65e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UGT1A1—lung cancer	7.07e-06	7.63e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6R—lung cancer	7e-06	7.56e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMS—lung cancer	7e-06	7.56e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CD—lung cancer	7e-06	7.55e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CREBBP—lung cancer	6.99e-06	7.55e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—lung cancer	6.92e-06	7.47e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOA1—lung cancer	6.92e-06	7.47e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—lung cancer	6.91e-06	7.45e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GNG11—lung cancer	6.82e-06	7.36e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAP2K1—lung cancer	6.68e-06	7.2e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CD—lung cancer	6.63e-06	7.15e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—STK11—lung cancer	6.63e-06	7.15e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.63e-06	7.15e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A1—lung cancer	6.56e-06	7.08e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ERCC2—lung cancer	6.51e-06	7.02e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDOA—lung cancer	6.49e-06	7.01e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—lung cancer	6.32e-06	6.82e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NCOA3—lung cancer	6.31e-06	6.8e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.22e-06	6.71e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADCY1—lung cancer	6.13e-06	6.62e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCG2—lung cancer	6.13e-06	6.62e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTP1—lung cancer	6.13e-06	6.61e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CB—lung cancer	6.1e-06	6.58e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—lung cancer	6.04e-06	6.52e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO2—lung cancer	6.01e-06	6.49e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HPGDS—lung cancer	6.01e-06	6.49e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—lung cancer	6.01e-06	6.49e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.98e-06	6.45e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAT—lung cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MDM2—lung cancer	5.94e-06	6.41e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.93e-06	6.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RAF1—lung cancer	5.92e-06	6.39e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CREBBP—lung cancer	5.86e-06	6.32e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—lung cancer	5.86e-06	6.32e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—lung cancer	5.83e-06	6.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—lung cancer	5.8e-06	6.26e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CB—lung cancer	5.78e-06	6.24e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTOR—lung cancer	5.78e-06	6.24e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—lung cancer	5.77e-06	6.22e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2A6—lung cancer	5.77e-06	6.22e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCLC—lung cancer	5.77e-06	6.22e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMS—lung cancer	5.7e-06	6.15e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—lung cancer	5.63e-06	6.08e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA1—lung cancer	5.63e-06	6.07e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CD—lung cancer	5.55e-06	5.99e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—lung cancer	5.48e-06	5.92e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO1—lung cancer	5.47e-06	5.9e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.39e-06	5.82e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A1—lung cancer	5.34e-06	5.76e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ERCC2—lung cancer	5.3e-06	5.72e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—lung cancer	5.27e-06	5.68e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—lung cancer	5.14e-06	5.55e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—EP300—lung cancer	5.03e-06	5.42e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—lung cancer	5.01e-06	5.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—lung cancer	5e-06	5.39e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2E1—lung cancer	4.9e-06	5.29e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—lung cancer	4.89e-06	5.28e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NQO1—lung cancer	4.85e-06	5.23e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CB—lung cancer	4.84e-06	5.22e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CREBBP—lung cancer	4.77e-06	5.14e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EP300—lung cancer	4.76e-06	5.14e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SRC—lung cancer	4.63e-06	5e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA1—lung cancer	4.58e-06	4.94e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CD—lung cancer	4.52e-06	4.88e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—lung cancer	4.47e-06	4.82e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—lung cancer	4.46e-06	4.81e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NRAS—lung cancer	4.46e-06	4.81e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.39e-06	4.73e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—STK11—lung cancer	4.37e-06	4.71e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—lung cancer	4.27e-06	4.6e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—lung cancer	4.18e-06	4.51e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—lung cancer	4.18e-06	4.51e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—lung cancer	4.15e-06	4.48e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—lung cancer	4.06e-06	4.38e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTP1—lung cancer	4.04e-06	4.36e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—EP300—lung cancer	3.99e-06	4.3e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—lung cancer	3.98e-06	4.3e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CB—lung cancer	3.94e-06	4.25e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAT—lung cancer	3.93e-06	4.25e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—lung cancer	3.9e-06	4.21e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CREBBP—lung cancer	3.88e-06	4.18e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—lung cancer	3.84e-06	4.14e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—lung cancer	3.83e-06	4.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMS—lung cancer	3.76e-06	4.06e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—lung cancer	3.72e-06	4.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—lung cancer	3.72e-06	4.01e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CD—lung cancer	3.68e-06	3.97e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—lung cancer	3.63e-06	3.92e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—lung cancer	3.52e-06	3.8e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A1—lung cancer	3.52e-06	3.8e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ERCC2—lung cancer	3.49e-06	3.77e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—lung cancer	3.4e-06	3.67e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—lung cancer	3.26e-06	3.52e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—EP300—lung cancer	3.25e-06	3.5e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CB—lung cancer	3.21e-06	3.46e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—lung cancer	3.18e-06	3.43e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—lung cancer	3.12e-06	3.37e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—lung cancer	3.04e-06	3.28e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA1—lung cancer	3.02e-06	3.26e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—lung cancer	2.95e-06	3.18e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—lung cancer	2.88e-06	3.11e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—lung cancer	2.77e-06	2.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—lung cancer	2.76e-06	2.98e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—EP300—lung cancer	2.64e-06	2.85e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—lung cancer	2.63e-06	2.83e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CREBBP—lung cancer	2.56e-06	2.76e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CD—lung cancer	2.43e-06	2.62e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—lung cancer	2.41e-06	2.6e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—lung cancer	2.4e-06	2.59e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—lung cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CB—lung cancer	2.11e-06	2.28e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—lung cancer	2.09e-06	2.26e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—lung cancer	1.96e-06	2.12e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—lung cancer	1.95e-06	2.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—lung cancer	1.83e-06	1.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EP300—lung cancer	1.74e-06	1.88e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—lung cancer	1.6e-06	1.72e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—lung cancer	1.29e-06	1.39e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—lung cancer	1.05e-06	1.14e-05	CbGpPWpGaD
